Marks Group Wealth Management Inc Increases Stock Holdings in Leidos Holdings, Inc. (NYSE:LDOS)

Marks Group Wealth Management Inc boosted its stake in Leidos Holdings, Inc. (NYSE:LDOS) by 0.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 58,115 shares of the aerospace company’s stock after acquiring an additional 415 shares during the period. Marks Group Wealth Management Inc’s holdings in Leidos were worth $9,473,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in LDOS. Northwest Investment Counselors LLC purchased a new position in shares of Leidos in the 3rd quarter valued at approximately $30,000. 1832 Asset Management L.P. bought a new stake in shares of Leidos during the 2nd quarter valued at $34,000. Blue Trust Inc. grew its position in shares of Leidos by 251.3% in the 2nd quarter. Blue Trust Inc. now owns 281 shares of the aerospace company’s stock worth $41,000 after buying an additional 201 shares during the period. Kathleen S. Wright Associates Inc. bought a new position in shares of Leidos in the 3rd quarter worth about $46,000. Finally, Massmutual Trust Co. FSB ADV increased its stake in shares of Leidos by 122.5% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 307 shares of the aerospace company’s stock worth $45,000 after acquiring an additional 169 shares in the last quarter. 76.12% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

LDOS has been the subject of several recent research reports. Truist Financial lifted their target price on shares of Leidos from $175.00 to $205.00 and gave the company a “buy” rating in a report on Wednesday, October 30th. The Goldman Sachs Group increased their target price on Leidos from $205.00 to $228.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Wells Fargo & Company lifted their price target on Leidos from $183.00 to $230.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 30th. Citigroup increased their price objective on shares of Leidos from $194.00 to $220.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th. Finally, Royal Bank of Canada upped their target price on shares of Leidos from $145.00 to $180.00 and gave the stock a “sector perform” rating in a research note on Wednesday, October 30th. Two research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Leidos currently has a consensus rating of “Moderate Buy” and an average price target of $191.23.

Insider Buying and Selling at Leidos

In other news, Director Robert C. Kovarik, Jr. sold 1,047 shares of the firm’s stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $184.94, for a total value of $193,632.18. Following the transaction, the director now owns 6,408 shares of the company’s stock, valued at $1,185,095.52. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Robert C. Kovarik, Jr. sold 1,047 shares of the stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $184.94, for a total value of $193,632.18. Following the completion of the sale, the director now directly owns 6,408 shares of the company’s stock, valued at $1,185,095.52. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Gary Stephen May sold 1,000 shares of the company’s stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $144.02, for a total transaction of $144,020.00. Following the completion of the transaction, the director now directly owns 11,264 shares of the company’s stock, valued at $1,622,241.28. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.96% of the stock is currently owned by corporate insiders.

Leidos Stock Performance

LDOS stock opened at $190.07 on Wednesday. The stock’s fifty day moving average price is $164.36 and its 200-day moving average price is $152.46. The company has a market cap of $25.36 billion, a P/E ratio of 21.65, a price-to-earnings-growth ratio of 1.45 and a beta of 0.68. Leidos Holdings, Inc. has a 1 year low of $102.21 and a 1 year high of $190.25. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.23 and a quick ratio of 1.15.

Leidos (NYSE:LDOS) last posted its quarterly earnings data on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.96 by $0.97. Leidos had a net margin of 7.37% and a return on equity of 30.31%. The company had revenue of $4.19 billion for the quarter, compared to the consensus estimate of $4.06 billion. During the same quarter last year, the firm posted $2.03 earnings per share. The firm’s revenue was up 6.9% compared to the same quarter last year. On average, equities analysts forecast that Leidos Holdings, Inc. will post 10.07 earnings per share for the current year.

Leidos Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 31st. Investors of record on Monday, December 16th will be issued a $0.40 dividend. This is a boost from Leidos’s previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a yield of 0.84%. The ex-dividend date is Friday, December 13th. Leidos’s dividend payout ratio (DPR) is currently 17.31%.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.